Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.7 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.062 | 0.7 |